In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

  • Everyone who has cancer or who knows someone with cancer should reach out to Cancer Commons. There is no better resource.

    Friend of a gastric cancer patient

  • The team was a great complement to my local oncology team! The findings of the analysis and tumor board recommendations helped confirm that our “First line standard of care” was corroborated and also offered a potential map of 2nd and 3rd line care. Further, clinical trials pertinent to my specific genomic cancer were identified with the closest providers currently offering trial enrollment.

    Mary Lou
    Metastatic colorectal cancer patient

  • Dr. Rahib is extremely helpful and I am very thankful to have access to such professional and state-of-the-art support.

    Ines
    Daughter of pancreatic cancer patient

  • The tumor board report summarized a lot of information into a very easy to read and understandable format. It provided contact information for additional treatment options which we will be pursuing. Lola Rahib was very efficient in obtaining all my medical records and responded quickly to our initial inquiry.

    Tony
    Pancreatic cancer patient

  • Emma Shtivelman is the best—bar none.

    Linda King-Byrnes

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.

  • Curious Dr. George logo, Cancer Commons logo, and photo of John H. Strickler, MD, Associate Professor of Medicine, Division
    NEW Curious Dr. George—How an Expert Would Manage His Own Stage 4 Pancreatic Cancer: An Update

    Here’s the latest from our Curious Dr. George! Read “How an Expert Would Manage His Own Stage 4 Pancreatic Cancer: An Update” here. When confronted with a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Previously, our Curious Dr. George asked John H. Strickler, MD, how he would handle his own hypothetical diagnosis of metastatic pancreatic cancer. Now, Dr.… Read more »

  • Curious Dr. George logo, Cancer Commons logo, and photo of Al B. Benson III, MD, FACP, FACCC, FASCO
    Curious Dr. George—How a Northwestern Professor Would Manage His Own Liver Cancer

    Here’s the latest from our Curious Dr. George! Read “How Would a Northwestern Professor Manage His Own Liver Cancer?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks liver cancer expert Al B. Benson III, MD, FACP, FACCC, FASCO, how he would handle his own hypothetical… Read more »

  • Curious Dr. George logo over Cancer Commons logo, with photo of sphygmomanometer and photo of Robert E. Matthews, President and CEO of MediSync (Cincinnati)
    Curious Dr. George—Successful Control of High Blood Pressure, a Major Cancer Comorbidity

    Here’s the latest from our Curious Dr. George! Read “Successful Control of High Blood Pressure, a Major Cancer Comorbidity” here. People with cancer often face additional health conditions, or “comorbidities,” that complicate treatment. High blood pressure, or hypertension, is a major comorbidity that affects many cancer patients. Our Curious Dr. George asks Robert E. Matthews, President and CEO of MediSync (Cincinnati), about how his… Read more »